Asahi Kasei Announces Agreement to Acquire ZOLL Medical

Builds on existing relationship to drive global development of critical care businesses

Asahi Kasei Corporation (TSE1: 3407, hereinafter: Asahi Kasei), and ZOLL Medical Corporation (NASDAQ GS: ZOLL, hereinafter: ZOLL) today jointly announced that Asahi Kasei, Japan’s leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction materials, and electronics sectors, has entered into a definitive merger agreement with ZOLL, a manufacturer of resuscitation and critical care devices and related software solutions, pursuant to which Asahi Kasei will acquire ZOLL for approximately $2.21 billion. The transaction has been approved by the Boards of Directors of both companies.

Nuance to Acquire Transcend

Accretive Transaction to Accelerate Adoption of Nuance Healthcare Solutions by Small- to Mid-Sized Hospital Market, Bring Strong Customer Base and Recurring Revenue

Nuance Communications, Inc. (NASDAQ: NUAN ) and Transcend Services, Inc. (NASDAQ: TRCR ) today announced a definitive agreement for Nuance to acquire Transcend, a leading provider of medical transcription and speech editing services, for approximately $300 million, net, in cash.

With Transcend, Nuance will accelerate access to and expand its customer base within the small- to mid-size hospital market, which comprises approximately 90 percent of hospitals in the U.S. and increasingly demands cost effective, voice-enabled, clinical documentation solutions to achieve Meaningful Use and the transition to ICD-10.

Sourcefire Announces Record Revenue for Fourth Quarter & Full Year 2011

Sourcefire, Inc. (Nasdaq:FIRE - News):

Fourth Quarter 2011:

    Revenue: $53.2 million, an increase of 40% year-over-year
    Adjusted Net Income: $7.6 million, or $0.25 per diluted share

Full Year 2011:

    Revenue: $165.6 million, an increase of 27% year-over-year
    Adjusted Net Income: $16.8 million, or $0.57 per diluted share

Mayo Clinic Selects Complete Genomics to Provide Outsourced Whole Genome Sequencing

Complete Genomics Inc. (Nasdaq:GNOM - News) announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its large-scale whole genome sequencing projects.

The Center for Individualized Medicine operates a comprehensive sequencing laboratory in its own Medical Genome Facility, but it determined that collaboration with Complete Genomics could supplement the services available to its community of medical researchers. Under the terms of the agreement, Mayo Clinic can send genetic material to Complete Genomics for sequencing and analysis. It will continue to operate and invest in its Medical Genome Facility. Financial details of the agreement were not disclosed.